On
The following tables present selected financial data from 2014 and 2013.
Years Ended December 31, |
|||||||
(in thousands, except per share amounts) |
2014 |
2013 |
|||||
Net income to shareholders |
$ |
321,182 |
$ |
281,021 |
|||
Comprehensive income to shareholders |
$ |
935,934 |
$ |
459,489 |
|||
Weighted average diluted shares |
14,057 |
12,586 |
|||||
Diluted net income per share |
$ |
22.27 |
$ |
22.48 |
|||
(in thousands, except per share amounts) |
December 31, 2014 |
December 31, 2013 |
|||||
Book value per common share outstanding |
$ |
543.96 |
$ |
477.16 |
|||
Common shares outstanding |
13,962 |
13,986 |
|||||
The increase in net income to shareholders during 2014 was driven by more favorable underwriting results and higher investment income, partially offset by higher income tax expense compared to 2013. The decrease in diluted net income per share during 2014 was due to the increase in weighted average diluted shares outstanding, which is attributable to shares issued in connection with the acquisition of Alterra in
Comprehensive income to shareholders for 2014 was
In conjunction with the continued integration of Alterra into our insurance operations, during the first quarter of 2014, we changed the way we aggregate and monitor our ongoing underwriting results. Effective
In
Combined Ratio Analysis |
|||
Years Ended December 31, |
|||
2014 |
2013 |
||
U.S. Insurance |
95% |
92% |
|
International Insurance |
93% |
94% |
|
Reinsurance |
96% |
109% |
|
Consolidated |
95% |
97% |
|
The consolidated combined ratio was 95% in 2014 compared to 97% in 2013. In 2014, a lower expense ratio was partially offset by a less favorable prior accident years' loss ratio compared to 2013. Underwriting, acquisition and insurance expenses in 2013 included transaction and other acquisition-related costs of
The 2014 combined ratio included
The combined ratio for the
The combined ratio for the
The combined ratio for the Reinsurance segment was 96% for 2014 compared to 109% for 2013. The decrease in the 2014 combined ratio was driven by a lower expense ratio and more favorable development of prior years' loss reserves compared to 2013. The Reinsurance segment's 2014 combined ratio included
Premium Analysis |
|||||||||||||||
Years Ended December 31, |
|||||||||||||||
Gross Written Premiums |
Earned Premiums |
||||||||||||||
(dollars in thousands) |
2014 |
2013 |
2014 |
2013 |
|||||||||||
U.S. Insurance |
$ |
2,493,823 |
$ |
2,252,739 |
$ |
2,022,860 |
$ |
1,727,766 |
|||||||
International Insurance |
1,200,403 |
1,101,099 |
909,679 |
833,984 |
|||||||||||
Reinsurance |
1,112,728 |
566,348 |
908,385 |
669,826 |
|||||||||||
Other Insurance (Discontinued Lines) |
(1,441) |
40 |
(12) |
40 |
|||||||||||
Total |
$ |
4,805,513 |
$ |
3,920,226 |
$ |
3,840,912 |
$ |
3,231,616 |
|||||||
Gross written premiums for 2014 increased 23% compared to 2013. The increase in gross premium volume was primarily due to the inclusion of premiums attributable to Alterra from
During 2013 and 2014, we have generally seen low to mid-single digit favorable rate changes in many of our product lines as market conditions improved and revenues, gross receipts and payrolls of our insureds were favorably impacted by improving economic conditions; however, during the fourth quarter of 2013 and continuing into 2014, we began to experience softening prices on our international catastrophe-exposed property product lines and in our property reinsurance book. We will continue to pursue price increases in 2015 when possible; however, when we believe the prevailing market price will not support our underwriting profit targets, the business is not written. As a result of our underwriting discipline, gross premium volume may vary when we alter our product offerings to maintain or improve underwriting profitability.
Net retention of gross premium volume was 82% for 2014 and 83% for 2013. The decrease in net retention in 2014 was due to a higher contribution of premium from Alterra. Historically, our products were written with limits that did not require significant reinsurance. Following the acquisition of Alterra, we have certain insurance and reinsurance products that use higher levels of reinsurance. We purchase reinsurance and retrocessional reinsurance in order to manage our net retention on individual risks and enable us to write policies with sufficient limits to meet policyholder needs.
Earned premiums for 2014 increased 19% compared to 2013. The increase was primarily driven by the increase in gross written premiums, as described above. Also contributing to the increase in earned premiums were higher earned premiums from our Hagerty business, which we began writing in the first quarter of 2013.
Net investment income for 2014 was
Net realized investment gains for 2014 were
Other revenues and other expenses include the results of
Invested assets were
At December 31, 2014, our holding company had
Net cash provided by operating activities was
Interest expense for 2014 was
Income tax expense for 2014 was 26% of our income before income taxes compared to 22% in 2013. In both periods, the effective tax rate differs from the statutory tax rate of 35% primarily as a result of tax-exempt investment income. The increase in the effective tax rate was driven by higher earnings taxed at 35% in 2014 and a smaller benefit from our foreign operations in 2014, which are taxed at a lower rate.
This release contains statements concerning or incorporating our expectations, assumptions, plans, objectives, future financial or operating performance and other statements that are not historical facts. These statements are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may use words such as "anticipate," "believe," "estimate," "expect," "intend," "predict," "project" and similar expressions as they relate to us or our management.
There are risks and uncertainties that may cause actual results to differ materially from predicted results in forward-looking statements. Factors that may cause actual results to differ are often presented with the forward-looking statements themselves. Additional factors that could cause actual results to differ from those predicted are set forth under "Risk Factors" and "Safe Harbor and Cautionary Statement" in our 2013 Annual Report on Form 10-K and most recent Quarterly Report on Form 10-Q or are included in the items listed below:
- our anticipated premium volume is based on current knowledge and assumes no significant man-made or natural catastrophes, no significant changes in products or personnel and no adverse changes in market conditions;
- the effect of cyclical trends, including demand and pricing in the insurance and reinsurance markets;
- actions by competitors, including consolidation, and the effect of competition on market trends and pricing;
- we offer insurance and reinsurance coverage against terrorist acts in connection with some of our programs, and in other instances we are legally required to offer terrorism insurance; in both circumstances, we actively manage our exposure, but if there is a covered terrorist attack, we could sustain material losses;
- the frequency and severity of man-made and natural catastrophes (including earthquakes and weather-related catastrophes) may exceed expectations, are unpredictable and, in the case of weather-related catastrophes, may be exacerbated if, as many forecast, conditions in the oceans and atmosphere result in increased hurricane, flood, drought or other adverse weather-related activity;
- emerging claim and coverage issues, changing legal and social trends, and inherent uncertainties (including but not limited to those uncertainties associated with our asbestos and environmental reserves) in the loss estimation process can adversely impact the adequacy of our loss reserves and our allowance for reinsurance recoverables;
- reinsurance reserves are subject to greater uncertainty than insurance reserves, primarily because of reliance upon the original underwriting decisions made by ceding companies and the longer lapse of time from the occurrence of loss events to their reporting to the reinsurer for ultimate resolution;
- changes in the assumptions and estimates used in establishing reserves for our life and annuity reinsurance book (which is in runoff), for example, changes in assumptions and estimates of mortality, longevity, morbidity and interest rates, could result in material increases in our estimated loss reserves for such business;
- adverse developments in insurance coverage litigation or other legal or administrative proceedings could result in material increases in our estimates of loss reserves;
- the failure of any loss limitation methods we employ;
- changes in the availability, costs and quality of reinsurance coverage, which may impact our ability to write certain lines of business;
- industry and economic conditions, deterioration in reinsurer credit quality and coverage disputes can affect the ability or willingness of reinsurers to pay balances due;
- after the commutation of ceded reinsurance contracts, any subsequent adverse development in the re-assumed loss reserves will result in a charge to earnings;
- regulatory actions can impede our ability to charge adequate rates and efficiently allocate capital;
- economic conditions, actual or potential defaults in sovereign debt obligations, volatility in interest and foreign currency exchange rates and changes in market value of concentrated investments can have a significant impact on the fair value of our fixed maturities and equity securities, as well as the carrying value of our other assets and liabilities, and this impact may be heightened by market volatility;
- a number of factors may adversely affect the markets served by our
Markel Ventures operations and negatively impact their revenues and profitability, including, among others: economic conditions; changes in government support for education, healthcare and infrastructure projects; changes in capital spending levels; changes in the housing market; and volatility in interest and foreign currency exchange rates; - economic conditions may adversely affect our access to capital and credit markets;
- we have substantial investments in municipal bonds (approximately
$4.3 billion atDecember 31, 2014 ) and, although less than 15% of our municipal bond portfolio is tied to any one state, widespread defaults could adversely affect our results of operations and financial condition; - the impacts of periods of slow economic growth; the continuing effects of government intervention into the markets to address financial downturns (including, among other things, the effects of the Dodd-Frank Wall Street Reform and Consumer Protection Act and regulations adopted thereunder); the outcome of economic and currency concerns in the Eurozone; material changes to the monetary policies of central banks, including the U.S. Federal Reserve and the
European Central Bank ; and the combined impact of the foregoing on our industry, business and investment portfolio; - the impacts that the political and civil unrest in
Ukraine and related sanctions imposed onRussia by the U.S. and other Western European governments may have on our businesses and the markets they serve or that any disruption in European or worldwide economic conditions generally arising from this situation may have on our business, industry or investment portfolio; - the impacts that the Israeli-Palestinian conflict may have on our businesses and the markets they serve or that any disruptions in Middle Eastern or worldwide economic conditions generally arising from this conflict may have on our business, industry or investment portfolio;
- the impacts that health epidemics and pandemics may have on our business operations and claims activity;
- the impact of the implementation of U.S. health care reform legislation and regulations under that legislation on our business;
- our business is dependent upon the successful functioning and security of our computer systems; if our information technology systems fail or suffer a security breach, our business or reputation could be adversely impacted;
- we have recently completed a number of acquisitions, which may increase our operational and control risks for a period of time;
- we may not realize the contemplated benefits, including cost savings and synergies, of our acquisitions;
- any determination requiring the write-off of a significant portion of our goodwill and intangible assets;
- the loss of services of any executive officer or other key personnel could adversely impact our operations;
- our expanding international operations expose us to increased investment, political and economic risks, including foreign currency and credit risk;
- the effectiveness of our procedures for compliance with existing and ever increasing guidelines, policies and legal and regulatory standards, rules, laws and regulations; and
- adverse changes in our assigned financial strength or debt ratings could adversely impact our ability to attract and retain business or obtain capital.
Our premium volume, underwriting and investment results and results from our non-insurance operations have been and will continue to be potentially materially affected by these factors. By making forward-looking statements, we do not intend to become obligated to publicly update or revise any such statements whether as a result of new information, future events or other changes. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as at their dates.
Our previously announced conference call, which will involve discussion of our financial results and business developments and may include forward-looking information, will be held
* * * * * * * *
Markel Corporation and Subsidiaries Consolidated Statements of Income and Comprehensive Income |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands, except per share data) |
2014 |
2013 |
2014 |
2013 |
|||||||||||
OPERATING REVENUES |
|||||||||||||||
Earned premiums |
$ |
971,931 |
$ |
962,487 |
$ |
3,840,912 |
$ |
3,231,616 |
|||||||
Net investment income |
93,250 |
88,585 |
363,230 |
317,373 |
|||||||||||
Net realized investment gains: |
|||||||||||||||
Other-than-temporary impairment losses |
(926) |
(117) |
(4,784) |
(4,706) |
|||||||||||
Net realized investment gains, excluding other-than-temporary |
18,217 |
22,568 |
50,784 |
67,858 |
|||||||||||
Net realized investment gains |
17,291 |
22,451 |
46,000 |
63,152 |
|||||||||||
Other revenues |
253,283 |
206,262 |
883,525 |
710,942 |
|||||||||||
Total Operating Revenues |
1,335,755 |
1,279,785 |
5,133,667 |
4,323,083 |
|||||||||||
OPERATING EXPENSES |
|||||||||||||||
Losses and loss adjustment expenses |
478,792 |
552,599 |
2,202,467 |
1,816,273 |
|||||||||||
Underwriting, acquisition and insurance expenses |
388,897 |
368,418 |
1,460,882 |
1,312,312 |
|||||||||||
Amortization of intangible assets |
16,635 |
17,468 |
57,627 |
55,223 |
|||||||||||
Other expenses |
256,568 |
203,886 |
854,871 |
663,528 |
|||||||||||
Total Operating Expenses |
1,140,892 |
1,142,371 |
4,575,847 |
3,847,336 |
|||||||||||
Operating Income |
194,863 |
137,414 |
557,820 |
475,747 |
|||||||||||
Interest expense |
28,306 |
31,250 |
117,442 |
114,004 |
|||||||||||
Income Before Income Taxes |
166,557 |
106,164 |
440,378 |
361,743 |
|||||||||||
Income tax expense |
48,335 |
7,225 |
116,690 |
77,898 |
|||||||||||
Net Income |
118,222 |
98,939 |
323,688 |
283,845 |
|||||||||||
Net income attributable to noncontrolling interests |
627 |
175 |
2,506 |
2,824 |
|||||||||||
Net Income to Shareholders |
$ |
117,595 |
$ |
98,764 |
$ |
321,182 |
$ |
281,021 |
|||||||
OTHER COMPREHENSIVE INCOME |
|||||||||||||||
Change in net unrealized gains on investments, net of taxes: |
|||||||||||||||
Net holding gains arising during the period |
$ |
339,639 |
$ |
118,072 |
$ |
687,735 |
$ |
225,545 |
|||||||
Change in unrealized other-than-temporary impairment losses on |
55 |
(101) |
173 |
(141) |
|||||||||||
Reclassification adjustments for net gains included in net income |
(10,409) |
(12,964) |
(26,161) |
(40,830) |
|||||||||||
Change in net unrealized gains on investments, net of taxes |
329,285 |
105,007 |
661,747 |
184,574 |
|||||||||||
Change in foreign currency translation adjustments, net of taxes |
(12,602) |
(212) |
(32,241) |
(10,143) |
|||||||||||
Change in net actuarial pension loss, net of taxes |
(15,714) |
2,919 |
(14,750) |
4,065 |
|||||||||||
Total Other Comprehensive Income |
300,969 |
107,714 |
614,756 |
178,496 |
|||||||||||
Comprehensive Income |
419,191 |
206,653 |
938,444 |
462,341 |
|||||||||||
Comprehensive income attributable to noncontrolling interests |
620 |
203 |
2,510 |
2,852 |
|||||||||||
Comprehensive Income to Shareholders |
$ |
418,571 |
$ |
206,450 |
$ |
935,934 |
$ |
459,489 |
|||||||
NET INCOME PER SHARE |
|||||||||||||||
Basic |
$ |
8.10 |
$ |
6.98 |
$ |
22.38 |
$ |
22.57 |
|||||||
Diluted |
$ |
8.05 |
$ |
6.95 |
$ |
22.27 |
$ |
22.48 |
|||||||
Selected Data |
December 31, |
||||||||||||||
(dollars and shares in thousands, except per share data) |
2014 |
2013 |
|||||||||||||
Total investments, cash and cash equivalents and restricted cash and |
$ |
18,637,701 |
$ |
17,612,074 |
|||||||||||
Reinsurance recoverable on paid and unpaid losses |
1,970,875 |
1,956,416 |
|||||||||||||
Goodwill |
1,049,115 |
967,717 |
|||||||||||||
Intangible assets |
702,747 |
565,083 |
|||||||||||||
Unpaid losses and loss adjustment expenses |
10,404,152 |
10,262,056 |
|||||||||||||
Unearned premiums |
2,245,690 |
2,127,115 |
|||||||||||||
Senior long-term debt and other debt |
2,253,594 |
2,256,227 |
|||||||||||||
Total shareholders' equity |
7,594,818 |
6,673,577 |
|||||||||||||
Book value per common share outstanding |
$ |
543.96 |
$ |
477.16 |
|||||||||||
Common shares outstanding |
13,962 |
13,986 |
Markel Corporation and Subsidiaries Supplemental Financial Information For the Quarters and Years Ended December 31, 2014 and 2013 |
|||||||||||||||
Underwriting Segment Gross Written Premiums |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2014 |
2013 |
2014 |
2013 |
|||||||||||
U.S. Insurance |
$ |
617,709 |
$ |
595,597 |
$ |
2,493,823 |
$ |
2,252,739 |
|||||||
International Insurance |
276,002 |
280,190 |
1,200,403 |
1,101,099 |
|||||||||||
Reinsurance |
113,692 |
123,856 |
1,112,728 |
566,348 |
|||||||||||
Other Insurance (Discontinued Lines) |
(1,475) |
5 |
(1,441) |
40 |
|||||||||||
Consolidated |
$ |
1,005,928 |
$ |
999,648 |
$ |
4,805,513 |
$ |
3,920,226 |
|||||||
Underwriting Segment Net Written Premiums |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2014 |
2013 |
2014 |
2013 |
|||||||||||
U.S. Insurance |
$ |
516,619 |
$ |
486,121 |
$ |
2,071,466 |
$ |
1,915,770 |
|||||||
International Insurance |
195,025 |
200,133 |
889,336 |
840,050 |
|||||||||||
Reinsurance |
100,654 |
117,223 |
956,584 |
480,822 |
|||||||||||
Other Insurance (Discontinued Lines) |
(706) |
6 |
(371) |
41 |
|||||||||||
Consolidated |
$ |
811,592 |
$ |
803,483 |
$ |
3,917,015 |
$ |
3,236,683 |
|||||||
Underwriting Segment Net Earned Premiums |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2014 |
2013 |
2014 |
2013 |
|||||||||||
U.S. Insurance |
$ |
523,289 |
$ |
487,909 |
$ |
2,022,860 |
$ |
1,727,766 |
|||||||
International Insurance |
230,907 |
238,684 |
909,679 |
833,984 |
|||||||||||
Reinsurance |
218,268 |
235,889 |
908,385 |
669,826 |
|||||||||||
Other Insurance (Discontinued Lines) |
(533) |
5 |
(12) |
40 |
|||||||||||
Consolidated |
$ |
971,931 |
$ |
962,487 |
$ |
3,840,912 |
$ |
3,231,616 |
|||||||
Underwriting Segment Combined Ratios |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
2014 |
2013 |
2014 |
2013 |
||||||||||||
U.S. Insurance |
90 |
% |
87 |
% |
95 |
% |
92 |
% |
|||||||
International Insurance |
86 |
% |
97 |
% |
93 |
% |
94 |
% |
|||||||
Reinsurance |
93 |
% |
112 |
% |
96 |
% |
109 |
% |
|||||||
Consolidated |
89 |
% |
96 |
% |
95 |
% |
97 |
% |
|||||||
Reconciliation of Segment Profit (Loss) to Consolidated Operating Income |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2014 |
2013 |
2014 |
2013 |
|||||||||||
U.S. Insurance (1) |
$ |
48,810 |
$ |
60,790 |
$ |
96,647 |
$ |
138,777 |
|||||||
International Insurance (1) |
30,961 |
5,823 |
70,437 |
51,446 |
|||||||||||
Reinsurance (1) |
15,278 |
(24,623) |
39,749 |
(55,550) |
|||||||||||
Other Insurance (Discontinued Lines) (1) |
(4,350) |
(13,514) |
(63,472) |
(57,426) |
|||||||||||
Investing |
110,541 |
111,036 |
409,230 |
380,525 |
|||||||||||
Other Revenues (Non-Insurance) |
246,679 |
200,226 |
854,893 |
686,448 |
|||||||||||
Other Expenses (Non-Insurance) |
(236,421) |
(184,856) |
(792,037) |
(613,250) |
|||||||||||
Amortization of Intangible Assets |
(16,635) |
(17,468) |
(57,627) |
(55,223) |
|||||||||||
Consolidated |
$ |
194,863 |
$ |
137,414 |
$ |
557,820 |
$ |
475,747 |
(1) |
Segment profit (loss) for our underwriting segments includes underwriting profit (loss) as well as other revenues and other expenses from our insurance operations. |
Other Revenues |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2014 |
2013 |
2014 |
2013 |
|||||||||||
Other Revenues (Insurance) |
|||||||||||||||
Managing general agent operations |
$ |
5,560 |
$ |
1,638 |
$ |
23,324 |
$ |
17,399 |
|||||||
Life and annuity |
423 |
651 |
1,631 |
1,130 |
|||||||||||
Other |
621 |
3,747 |
3,677 |
5,965 |
|||||||||||
Insurance Other Revenues |
6,604 |
6,036 |
28,632 |
24,494 |
|||||||||||
Other Revenues (Non-Insurance) |
|||||||||||||||
Markel Ventures: Manufacturing |
179,905 |
113,871 |
575,353 |
495,138 |
|||||||||||
Markel Ventures: Non-Manufacturing |
63,310 |
86,355 |
262,767 |
191,310 |
|||||||||||
Other |
3,464 |
— |
16,773 |
— |
|||||||||||
Non-Insurance Other Revenues |
246,679 |
200,226 |
854,893 |
686,448 |
|||||||||||
Consolidated Other Revenues |
$ |
253,283 |
$ |
206,262 |
$ |
883,525 |
$ |
710,942 |
|||||||
Other Expenses |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2014 |
2013 |
2014 |
2013 |
|||||||||||
Other Expenses (Insurance) |
|||||||||||||||
Managing general agent operations |
$ |
7,596 |
$ |
3,533 |
$ |
22,527 |
$ |
20,382 |
|||||||
Life and annuity |
11,517 |
15,087 |
37,132 |
28,126 |
|||||||||||
Other |
1,034 |
410 |
3,175 |
1,770 |
|||||||||||
Insurance Other Expenses |
20,147 |
19,030 |
62,834 |
50,278 |
|||||||||||
Other Expenses (Non-Insurance) |
|||||||||||||||
Markel Ventures: Manufacturing |
158,188 |
101,781 |
513,668 |
437,712 |
|||||||||||
Markel Ventures: Non-Manufacturing |
75,903 |
83,075 |
261,551 |
175,538 |
|||||||||||
Other |
2,330 |
— |
16,818 |
— |
|||||||||||
Non-Insurance Other Expenses |
236,421 |
184,856 |
792,037 |
613,250 |
|||||||||||
Consolidated Other Expenses |
$ |
256,568 |
$ |
203,886 |
$ |
854,871 |
$ |
663,528 |
|||||||
Reconciliation of Non-GAAP Financial Measure |
|||||||||||||||
The following table reconciles earnings before goodwill impairment, interest, income taxes, depreciation and amortization (Adjusted EBITDA) of Markel Ventures to consolidated net income to shareholders. |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2014 |
2013 |
2014 |
2013 |
|||||||||||
Markel Ventures Adjusted EBITDA - Manufacturing |
$ |
24,778 |
$ |
14,281 |
$ |
71,133 |
$ |
64,415 |
|||||||
Markel Ventures Adjusted EBITDA - Non-Manufacturing |
4,168 |
5,265 |
23,931 |
19,372 |
|||||||||||
Markel Ventures Adjusted EBITDA - Total |
28,946 |
19,546 |
95,064 |
83,787 |
|||||||||||
Goodwill impairment |
(13,737) |
— |
(13,737) |
— |
|||||||||||
Interest expense |
(3,792) |
(2,274) |
(12,184) |
(9,283) |
|||||||||||
Income tax expense |
(3,431) |
(1,957) |
(12,848) |
(13,988) |
|||||||||||
Depreciation expense |
(7,213) |
(5,185) |
(24,706) |
(19,313) |
|||||||||||
Amortization of intangible assets |
(7,526) |
(4,481) |
(22,032) |
(17,383) |
|||||||||||
Markel Ventures net income (loss) to shareholders |
(6,753) |
5,649 |
9,557 |
23,820 |
|||||||||||
Net income from other Markel operations |
124,348 |
93,115 |
311,625 |
257,201 |
|||||||||||
Net income to shareholders |
$ |
117,595 |
$ |
98,764 |
$ |
321,182 |
$ |
281,021 |
|||||||
Interest expense for the quarters ended December 31, 2014 and 2013 includes intercompany interest expense of $2.9 million and $1.6 million, respectively. Interest expense for the years ended December 31, 2014 and 2013 includes intercompany interest expense of $8.7 million and $6.4 million, respectively. |
Markel Ventures Adjusted EBITDA is a non-GAAP financial measure and is reconciled to consolidated net income to shareholders in the above table. Markel Ventures Adjusted EBITDA reflects income attributable to our ownership interest in Markel Ventures before goodwill impairment, interest, income taxes, depreciation and amortization. We use Markel Ventures Adjusted EBITDA as an operating performance measure in conjunction with U.S. GAAP measures, including revenues and net income, to monitor and evaluate the performance of our Markel Ventures operations. |
Net Income per Share |
|||||||||||||||
Net income per share was determined by dividing adjusted net income to shareholders by the applicable weighted average shares outstanding. Diluted net income per share is computed by dividing adjusted net income to shareholders by the weighted average number of common shares and dilutive potential common shares outstanding during the year. |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(in thousands, except per share amounts) |
2014 |
2013 |
2014 |
2013 |
|||||||||||
Net income to shareholders |
$ |
117,595 |
$ |
98,764 |
$ |
321,182 |
$ |
281,021 |
|||||||
Adjustment of redeemable noncontrolling interests |
(4,343) |
(1,138) |
(8,186) |
1,963 |
|||||||||||
Adjusted net income to shareholders |
$ |
113,252 |
$ |
97,626 |
$ |
312,996 |
$ |
282,984 |
|||||||
Basic common shares outstanding |
13,976 |
13,987 |
13,984 |
12,538 |
|||||||||||
Dilutive potential common shares from conversion of |
10 |
14 |
11 |
12 |
|||||||||||
Dilutive potential common shares from conversion of |
77 |
48 |
62 |
36 |
|||||||||||
Diluted shares outstanding |
14,063 |
14,049 |
14,057 |
12,586 |
|||||||||||
Basic net income per share |
$ |
8.10 |
$ |
6.98 |
$ |
22.38 |
$ |
22.57 |
|||||||
Diluted net income per share |
$ |
8.05 |
$ |
6.95 |
$ |
22.27 |
$ |
22.48 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/markel-reports-2014-financial-results-300034824.html
SOURCE
Bruce Kay, Markel Corporation, 804-747-0136, bkay@markelcorp.com